+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 18Years +
All Genders
ID05377905

Phase 1b2 Study Testing Microneedle Patch Delivering Low-dose Doxorubicin for Skin Squamous Cell Cancer in Patients With Normal or Suppressed Immune Systems

Led by Falo, Louis, MD · Updated on 2026-04-09

48

Participants Needed

1

Research Sites

39 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a new experimental treatment for cutaneous squamous cell carcinoma cSCC, a type of skin cancer, using small adhesive patches called microneedle arrays MNA. These patches contain tiny needles loaded with very low doses of doxorubicin, a chemotherapy drug. The study aims to test the safety and effectiveness of these patches in both patients with normal immune systems and those who are immunosuppressed due to organ transplants. The treatment involves applying the MNA-Doxorubicin patches directly to the cancerous skin lesion for 20 minutes once a week over four weeks. After these applications, there is a rest period followed by a final follow-up visit between weeks 5 and 8. At the final visit, any remaining cancerous tissue will be surgically removed using standard care procedures to ensure complete treatment. Participants will undergo regular evaluations including skin assessments where the patches are applied, blood tests, and tissue analyses to monitor treatment responses and safety. Researchers will measure adverse events, tumor response, immune system activity, and tumor clearance. The entire study period spans from screening to final follow-up at around 8 weeks, with ongoing safety monitoring throughout.

CONDITIONS

Brief Title

Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC)

Research Team

C

Charity L Ruhl, LPN

N

Nicolena Verardi

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here